Senator Charles Grassley, the Iowa Republican who for over a year has been leading an investigation rooting out academic researchers with undisclosed industry ties also found that a popular National Public Radio (NPR) host of the health and science show, “The Infinite Mind,” has a conflict-of-interest with the very drug companies he talks about.

The psychiatrist and former National Institute of Mental Health (NIMH) director Dr. Frederick K. Goodwin collected some $1.3 million from drugmakers between 2000 and 2007. However, Goodwin never mentioned those payments to listeners, despite the fact that some of his programs dealt with subjects "important to the commercial interests of the companies for which he consults," the New York Times reports.

For example, in a September 2005 program, he suggested that children with bipolar disorder (affection he frequently talked about, as well as other frequent mental health disorders) who do not undergo treatment could suffer brain damage. He has often suggested to his audience that “mood stabilizers” are safe and effective in bipolar children.

But on the day he discussed mood stabilizers for children on his show, Dr. Goodwin took $2,500 from GlaxoSmithKline to promote “Lamictal,” a mood stabilizer, during one lecture at the Ritz Carlton Golf Resort in Naples, Florida. Altogether that year he collected another $329,000 for promoting the drug. Grassley uncovered about nine drug makers that fund Dr. Goodwin.

Goodwin told the New York Times that the radio show's producer, Bill Lichtenstein of Lichtenstein Creative Media, knew about his consulting with drugmakers, but that neither he nor the producer realized at the time that they should have disclosed the relationships. But the producer denied, telling the paper that Goodwin didn’t mention his getting money from drugmakers.